
FDA Commissioner Marty Makary testifies before the Senate Appropriations Committee on May 22, 2025 (Drew Angerer/AFP via Getty Images)
FDA chief to senators: 3,000+ staff departures won't delay user fee targets
FDA Commissioner Marty Makary defended thousands of staff cuts during his first congressional hearing since taking office, seeking to reassure senators that review timelines for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.